Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Berkowitz

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Oncogene|August 8, 1998
DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseasesV Fulop, C V Colitti, D Genest, et al.
Gynecologic Oncology|March 31, 2000
ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneumA P Garrett, S W Ng, M G Muto, et al.
Oncogene|February 17, 1998
A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumorsM I Edelson, C C Lau, C V Colitti, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Oncogene|April 22, 2000
Analysis of p73 in human borderline and invasive ovarian tumorS W Ng, G K Yiu, Y Liu, et al.
The American Journal of Pathology|February 10, 2000
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancersW Y Chan, K K Cheung, J O Schorge, et al.
American Journal of Clinical Pathology|July 8, 2000
Distinct allelic loss patterns in papillary serous carcinoma of the peritoneumL W Huang, A P Garrett, J O Schorge, et al.
Cancer Research|October 5, 2001
Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumorsB H Ortiz, M Ailawadi, C Colitti, et al.
Cancer Research|April 1, 1993
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancyS C Mok, D A Bell, R C Knapp, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Oncogene|August 8, 1998
DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseasesV Fulop, C V Colitti, D Genest, et al.
Gynecologic Oncology|March 31, 2000
ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneumA P Garrett, S W Ng, M G Muto, et al.
Oncogene|February 17, 1998
A one centimorgan deletion unit on chromosome Xq12 is commonly lost in borderline and invasive epithelial ovarian tumorsM I Edelson, C C Lau, C V Colitti, et al.
Gynecologic Oncology|September 1, 1992
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaH M Goodman, B L Harlow, E E Sheets, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomyK H Lu, J E Garber, D W Cramer, et al.
Oncogene|April 22, 2000
Analysis of p73 in human borderline and invasive ovarian tumorS W Ng, G K Yiu, Y Liu, et al.
The American Journal of Pathology|February 10, 2000
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancersW Y Chan, K K Cheung, J O Schorge, et al.
American Journal of Clinical Pathology|July 8, 2000
Distinct allelic loss patterns in papillary serous carcinoma of the peritoneumL W Huang, A P Garrett, J O Schorge, et al.
Cancer Research|October 5, 2001
Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumorsB H Ortiz, M Ailawadi, C Colitti, et al.
Cancer Research|April 1, 1993
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancyS C Mok, D A Bell, R C Knapp, et al.
Pageof 19